Analyzing specific forms of the Akt protein in live cells
Live Cell Isoform-specific Akt Analyses
['FUNDING_R15'] · TEXAS TECH UNIVERSITY · NIH-11037142
This study is looking at different versions of a protein called Akt in living cells to learn how they work together, which could help develop better treatments for patients in the future.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS TECH UNIVERSITY (nih funded) |
| Locations | 1 site (LUBBOCK, UNITED STATES) |
| Trial ID | NIH-11037142 on ClinicalTrials.gov |
What this research studies
This research focuses on the analysis of different isoforms of the Akt protein within live cells. By acquiring advanced equipment, the study aims to enhance our understanding of how these protein variants function and interact in cellular processes. Patients may benefit indirectly through improved knowledge that could lead to better-targeted therapies in the future. The methodology involves live cell imaging and biochemical assays to observe the behavior of these protein isoforms in real-time.
Who could benefit from this research
Good fit: Ideal candidates for potential benefit are individuals with conditions linked to Akt protein abnormalities, such as certain cancers or metabolic disorders.
Not a fit: Patients with conditions unrelated to Akt protein functions may not receive any direct benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for diseases related to Akt protein dysfunction.
How similar studies have performed: While this specific approach is focused on isoform-specific analysis, similar studies have shown promise in understanding protein functions and their implications in disease.
Where this research is happening
LUBBOCK, UNITED STATES
- TEXAS TECH UNIVERSITY — LUBBOCK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, DEGENG — TEXAS TECH UNIVERSITY
- Study coordinator: WANG, DEGENG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.